Biechele Royce Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $17.8M | Buy |
197,754
+7,612
| +4% | +$685K | 5.87% | 5 |
|
2024
Q2 | $15M | Buy |
190,142
+9,681
| +5% | +$762K | 5.05% | 6 |
|
2024
Q1 | $15.7M | Buy |
180,461
+1,113
| +0.6% | +$97K | 5.22% | 7 |
|
2023
Q4 | $14.8M | Buy |
179,348
+16,343
| +10% | +$1.35M | 4.84% | 7 |
|
2023
Q3 | $12.8M | Buy |
163,005
+8,876
| +6% | +$696K | 4.71% | 9 |
|
2023
Q2 | $13.6M | Buy |
154,129
+19,366
| +14% | +$1.71M | 4.73% | 7 |
|
2023
Q1 | $10.9M | Buy |
134,763
+15,244
| +13% | +$1.23M | 4.04% | 11 |
|
2022
Q4 | $9.29M | Buy |
+119,519
| New | +$9.29M | 3.79% | 12 |
|